Evogene Financial Results for the Second Quarter of 2017 Earnings Announcement Schedule
July 20 2017 - 7:00AM
Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading company for the
improvement of crop productivity and economics for food, feed and
biofuel industries, announced today that it will release its
financial results for the second quarter of 2017 on Thursday,
August 10, 2017.
On the day of the announcement, the Company’s
management will host a conference call to discuss the results at
09:00 AM Eastern time, 16:00 Israel time. To access the conference
call, please dial 1-888-668-9141 toll free from the United States,
or +972-3-918-0644 internationally. Access to the call will also be
available via live webcast through the Company’s website at
www.evogene.com.
A replay of the conference call will be
available approximately three hours following the completion of the
call. To access the replay, please dial 1-888-254-7270 toll free
from the United States, or +972-3-925-5940 internationally. The
replay will be accessible through August 12, 2017, and an archive
of the webcast will be available on the Company’s website through
August 20, 2017.
About Evogene Ltd.:Evogene
(NASDAQ:EVGN) (TASE:EVGN) is a leading biotechnology company for
the improvement of crop productivity for the food, feed and fuel
industries. The Company operates in three key target markets:
improved seed traits (addressing yield increase, tolerance to
environmental stresses and resistance to insects and diseases);
innovative ag-chemicals (developing novel herbicide solutions for
weed control); and ag-biologicals. Evogene has collaborations with
world-leading seed and ag-chemical companies. For more information,
please visit www.evogene.com or contact the Company at
info@evogene.com.
Forward Looking Statements:This
press release contains “forward-looking statements” relating to
future events. These statements may be identified by words such as
“may”, “could”, “expects”, "intends", “anticipates”, “plans”,
“believes”, “scheduled”, “estimates” or words of similar meaning.
Such statements are based on current expectations, estimates,
projections and assumptions, describe opinions about future events,
involve certain risks and uncertainties which are difficult to
predict and are not guarantees of future performance. Therefore,
actual future results, performance or achievements of Evogene may
differ materially from what is expressed or implied by such
forward-looking statements due to a variety of factors, many of
which beyond Evogene's control, including, without limitation,
those risk factors contained in Evogene’s reports filed with the
appropriate securities authority. Evogene disclaims any obligation
or commitment to update these forward-looking statements to reflect
future events or developments or changes in expectations,
estimates, projections and assumptions.
Contact:
Alex Taskar
Chief Financial Officer
E: IR@evogene.com
T: (+972)-8-931-1963
Evogene (NASDAQ:EVGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Evogene (NASDAQ:EVGN)
Historical Stock Chart
From Apr 2023 to Apr 2024